{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:43:37Z","timestamp":1792172617039,"version":"4.4.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.arteri.2020.12.013","type":"journal-article","created":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T08:40:25Z","timestamp":1621068025000},"page":"43-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"S2","title":["Hiperlipemia familiar combinada\/hiperlipemia mixta polig\u00e9nica"],"prefix":"10.1016","volume":"33","author":[{"given":"Juan","family":"Pedro-Botet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisenda","family":"Climent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Gabarr\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Mill\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arteri.2020.12.013_bib0225","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1172\/JCI107332","article-title":"Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia","volume":"52","author":"Goldstein","year":"1973","journal-title":"J Clin Invest."},{"key":"10.1016\/j.arteri.2020.12.013_bib0230","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1172\/JCI107333","article-title":"Hyperlipidemia in coronary heart disease. 3. Evaluation of lipoprotein phenotypes of 156 genetically defined survivors of myocardial infarction","volume":"52","author":"Hazzard","year":"1973","journal-title":"J Clin Invest."},{"key":"10.1016\/j.arteri.2020.12.013_bib0235","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1172\/JCI107670","article-title":"Familial hypercholesterolemia (one form of familial type II hyperlipoproteinemia). A study of its biochemical, genetic and clinical presentation in childhood","volume":"53","author":"Kwiterovich","year":"1974","journal-title":"J Clin Invest."},{"key":"10.1016\/j.arteri.2020.12.013_bib0240","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1253\/circj.CJ-12-0320","article-title":"Impact of cardiometabolic risk factors on major cardiovascular events in patients with familial combined hyperlipidemia","volume":"77","author":"Skoumas","year":"2013","journal-title":"Circ J."},{"key":"10.1016\/j.arteri.2020.12.013_bib0245","first-page":"224","article-title":"Familial combined hyperlipidemia: current knowledge, perspectives, and controversies","volume":"70","author":"Bello-Chavolla","year":"2018","journal-title":"Rev Invest Clin."},{"key":"10.1016\/j.arteri.2020.12.013_bib0250","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.atherosclerosis.2007.11.021","article-title":"Prevalence and determinants of coronary artery disease in males and females with familial combined hyperlipidaemia","volume":"199","author":"Pitsavos","year":"2008","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.arteri.2020.12.013_bib0255","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/MOL.0000000000000068","article-title":"Familial combined hyperlipidemia: from molecular insights to tailored therapy","volume":"25","author":"Van Greevenbroek","year":"2014","journal-title":"Curr Opin Lipidol."},{"key":"10.1016\/j.arteri.2020.12.013_bib0260","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/eurheartj\/ehp051","article-title":"Familial combined hyperlipidaemia in very young myocardial infarction survivors (< or =40 years of age)","volume":"30","author":"Wiesbauer","year":"2009","journal-title":"Eur Heart J."},{"key":"10.1016\/j.arteri.2020.12.013_bib0265","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrendo.2012.15","article-title":"The genetics of familial combined hyperlipidaemia","volume":"8","author":"Brouwers","year":"2012","journal-title":"Nat Rev Endocrinol."},{"key":"10.1016\/j.arteri.2020.12.013_bib0270","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1161\/hq0202.104059","article-title":"Diagnosis of familial combined hyperlipidemia based on lipid phenotype expression in 32 families: results of a 5-year follow-up study","volume":"22","author":"Veerkamp","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"10.1016\/j.arteri.2020.12.013_bib0275","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1161\/01.CIR.0000130646.93255.86","article-title":"Nomogram to diagnose familial combined hyperlipidemia on the basis of results of a 5-year follow-up study","volume":"109","author":"Veerkamp","year":"2004","journal-title":"Circulation."},{"key":"10.1016\/j.arteri.2020.12.013_bib0280","series-title":"Lipidolog\u00eda Cl\u00ednica","first-page":"101","article-title":"Dislipidemias mixtas","author":"Real","year":"2017"},{"key":"10.1016\/j.arteri.2020.12.013_bib0285","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1136\/jmg.2008.059980","article-title":"A PCSK9 variant and familial combined hyperlipidaemia","volume":"45","author":"Abifadel","year":"2008","journal-title":"J Med Genet."},{"key":"10.1016\/j.arteri.2020.12.013_bib0290","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1042\/CS20110129","article-title":"Plasma proprotein convertase subtilisin kexin type 9 is a heritable trait of familial combined hyperlipidaemia","volume":"121","author":"Brouwers","year":"2011","journal-title":"Clin Sci (Lond)."},{"key":"10.1016\/j.arteri.2020.12.013_bib0295","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1373\/clinchem.2009.128645","article-title":"Plasma proprotein convertase subtilisin\/kexin type 9: a marker of LDL apolipoprotein B-100 catabolism?","volume":"55","author":"Chan","year":"2009","journal-title":"Clin Chem."},{"key":"10.1016\/j.arteri.2020.12.013_bib0300","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1161\/01.ATV.0000222907.72985.0b","article-title":"Identification of a novel C5L2 variant (S323I) in a French Canadian family with familial combined hyperlipemia","volume":"26","author":"Marcil","year":"2006","journal-title":"Arterioscler Thromb Vasc."},{"key":"10.1016\/j.arteri.2020.12.013_bib0305","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.jacc.2008.06.050","article-title":"Frequency of low-density lipoprotein receptor gene mutations in patients with a clinical diagnosis of familial combined hyperlipidemia in a clinical setting","volume":"52","author":"Civeira","year":"2008","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.arteri.2020.12.013_bib0310","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.2337\/db08-0516","article-title":"Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations","volume":"57","author":"Orho-Melander","year":"2008","journal-title":"Diabetes."},{"key":"10.1016\/j.arteri.2020.12.013_bib0315","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.atherosclerosis.2012.03.011","article-title":"Apolipoprotein E gene mutations in subjects with mixed hyperlipidemia and a clinical diagnosis of familial combined hyperlipidemia","volume":"222","author":"Solanas-Barca","year":"2012","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.arteri.2020.12.013_bib0320","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00109-009-0490-z","article-title":"OSBPL10, a novel candidate gene for high triglyceride trait in dyslipidemic Finnish subjects, regulates cellular lipid metabolism","volume":"87","author":"Perttil\u00e4","year":"2009","journal-title":"J Mol Med."},{"key":"10.1016\/j.arteri.2020.12.013_bib0325","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1074\/jbc.274.4.2009","article-title":"Essential role in vivo of upstream stimulatory factors for a normal dietary response of the fatty acid synthase gene in the liver","volume":"274","author":"Casado","year":"1999","journal-title":"J Biol Chem."},{"key":"10.1016\/j.arteri.2020.12.013_bib0330","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0009-8981(02)00420-5","article-title":"Intra-individual variations of fasting plasma lipids, apolipoproteins and postprandial lipemia in familial combined hyperlipidemia compared to controls","volume":"328","author":"Delawi","year":"2003","journal-title":"Clin Chim Acta."},{"key":"10.1016\/j.arteri.2020.12.013_bib0335","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1002\/iub.2073","article-title":"Familial combined hyperlipidemia: an overview of the underlying molecular mechanisms and therapeutic strategies","volume":"71","author":"Taghizadeh","year":"2019","journal-title":"IUBMB Life."},{"key":"10.1016\/j.arteri.2020.12.013_bib0340","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature10426","article-title":"Dynamics of human adipose lipid turnover in health and metabolic disease","volume":"478","author":"Arner","year":"2011","journal-title":"Nature."},{"key":"10.1016\/j.arteri.2020.12.013_bib0345","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1046\/j.1365-2362.2001.00813.x","article-title":"The hormone sensitive lipase gene in familial combined hyperlipidemia and insulin resistance","volume":"31","author":"Pihlajam\u00e4ki","year":"2001","journal-title":"Eur J Clin Invest."},{"key":"10.1016\/j.arteri.2020.12.013_bib0350","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.atherosclerosis.2010.08.055","article-title":"Genetic variants in adipose triglyceride lipase influence lipid levels in familial combined hyperlipidemia","volume":"213","author":"Nanni","year":"2010","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.arteri.2020.12.013_bib0355","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/ng1320","article-title":"Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1)","volume":"36","author":"Pajukanta","year":"2004","journal-title":"Nat Genet."},{"key":"10.1016\/j.arteri.2020.12.013_bib0360","doi-asserted-by":"crossref","first-page":"323ra13","DOI":"10.1126\/scitranslmed.aad0015","article-title":"USF1 deficiency activates brown adipose tissue and improves cardiometabolic health","volume":"8","author":"Laurila","year":"2016","journal-title":"Sci Transl Med."},{"key":"10.1016\/j.arteri.2020.12.013_bib0365","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/sj.ijo.0803234","article-title":"The Gln223Arg polymorphism in the leptin receptor is associated with familial combined hyperlipidemia","volume":"30","author":"Van der Vleuten","year":"2006","journal-title":"Int J Obes (Lond)."},{"key":"10.1016\/j.arteri.2020.12.013_bib0370","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0021-9150(99)00433-5","article-title":"The Pro12Ala substitution in the peroxisome proliferator activated receptor gamma 2 is associated with an insulin-sensitive phenotype in families with familial combined hyperlipidemia and in nondiabetic elderly subjects with dyslipidemia","volume":"151","author":"Pihlajam\u00e4ki","year":"2000","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.arteri.2020.12.013_bib0375","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.cca.2014.08.018","article-title":"Determinants of VLDL composition and apo B-containing particles in familial combined hyperlipidemia","volume":"438","author":"Cruz-Bautista","year":"2015","journal-title":"Clin Chim Acta."},{"key":"10.1016\/j.arteri.2020.12.013_bib0380","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.jacc.2011.11.064","article-title":"Discovery of a new role of human resistin in hepatocyte low-density lipoprotein receptor suppression mediated in part by proprotein convertase subtilisin\/kexin type 9","volume":"59","author":"Melone","year":"2012","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.arteri.2020.12.013_bib0385","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.bbrc.2008.08.111","article-title":"Adiponectin multimer distribution in patients with familial combined hyperlipidemia","volume":"376","author":"Koenen","year":"2008","journal-title":"Biochem Biophys Res Commun."},{"key":"10.1016\/j.arteri.2020.12.013_bib0390","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0140-6736(11)61931-4","article-title":"Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies","volume":"379","author":"Sarwar","year":"2012","journal-title":"Lancet."},{"key":"10.1016\/j.arteri.2020.12.013_bib0395","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1161\/01.CIR.0000081777.17879.85","article-title":"Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia","volume":"108","author":"Hopkins","year":"2003","journal-title":"Circulation."},{"key":"10.1016\/j.arteri.2020.12.013_bib0400","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/01.ATV.17.4.748","article-title":"Defects of insulin action on fatty acid and carbohydrate metabolism in familial combined hyperlipidemia","volume":"17","author":"Aitman","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"10.1016\/j.arteri.2020.12.013_bib0405","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1161\/01.ATV.0000160612.18065.29","article-title":"Role of insulin resistance in familial combined hyperlipidemia","volume":"25","author":"Veerkamp","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"10.1016\/j.arteri.2020.12.013_bib0410","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.ajhg.2013.10.019","article-title":"Joint linkage and association analysis with exome sequence data implicates SLC25A40 in hypertriglyceridemia","volume":"93","author":"Rosenthal","year":"2013","journal-title":"Am J Hum Genet."},{"key":"10.1016\/j.arteri.2020.12.013_bib0415","first-page":"1","article-title":"Est\u00e1ndares SEA 2019 para el control global del riesgo cardiovascular","volume":"31","author":"Mostaza","year":"2019","journal-title":"Clin Investig Arterioscler."},{"key":"10.1016\/j.arteri.2020.12.013_bib0420","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nrendo.2016.69","article-title":"Progress in the care of common inherited atherogenic disorders of apolipoprotein B metabolism","volume":"12","author":"Ellis","year":"2016","journal-title":"Nat Rev Endocrinol."},{"key":"10.1016\/j.arteri.2020.12.013_bib0425","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/174182670200900105","article-title":"Atorvastatin versus four-statin-fibrate combinations in patients with familial combined hyperlipidaemia","volume":"9","author":"Athyros","year":"2002","journal-title":"J Cardiovasc Risk."},{"key":"10.1016\/j.arteri.2020.12.013_bib0430","first-page":"49","article-title":"MTP gene polymorphisms and postprandial lipemia in familial combined hyperlipidemia: effects of treatment with atorvastatin","volume":"26","author":"Klop","year":"2014","journal-title":"Clin Investig Arterioscler."},{"key":"10.1016\/j.arteri.2020.12.013_bib0435","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0021-9150(99)00267-1","article-title":"Omacor in familial combined hyperlipidemia: effects on lipids and low density lipoprotein subclasses","volume":"148","author":"Calabressi","year":"2000","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.arteri.2020.12.013_bib0440","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2217\/clp.15.37","article-title":"Effects of Armolipid Plus on small dense LDL particles in a sample of patients affected by familial combined hyperlipidemia","volume":"10","author":"Gentile","year":"2015","journal-title":"Clin Lipidol."}],"container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916821000164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916821000164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:33:23Z","timestamp":1759325603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0214916821000164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":44,"alternative-id":["S0214916821000164"],"URL":"https:\/\/doi.org\/10.1016\/j.arteri.2020.12.013","relation":{},"ISSN":["0214-9168"],"issn-type":[{"value":"0214-9168","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hiperlipemia familiar combinada\/hiperlipemia mixta polig\u00e9nica","name":"articletitle","label":"Article Title"},{"value":"Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arteri.2020.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Sociedad Espa\u00f1ola de Arteriosclerosis. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}